Merck Plans to Onshore Production in Virginia
Merck & Co., a US-based pharmaceutical company known outside the US as MSD, is investing $3 billion to build a 400,000 square-foot pharmaceutical manufacturing facility in Elkton, Virginia.
The facility will be Merck’s center of excellence for small-molecule manufacturing and testing. The investment is a response to the call to bring back manufacturing operations and R&D domestically.
Incentives ranging from grants to economic development partnerships to talent accelerator programs also play a role in Merck’s expansion decision.
Video Spotlight:


